Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double trigger versus conventional antagonist ovarian stimulation in poor prognosis women undergoing IVF/ICSI
2019-000971-17Phase 4Completed
- Sponsor
- UZ Brussel
- Start
- May 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of corifollitropin alfa and follitropin beta in infertility (2 arms), sponsored by UZ Brussel. Primary endpoint: Number of metaphase II oocytes. Started May 2019; status: completed.
02
Drugs
corifollitropin alfafollitropin beta
03
Conditions
infertility
Beyond the preview
Go deeper on 2019-000971-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000971-17.